Page last updated: 2024-10-24

carbamazepine and Glomerulonephritis, Membranous

carbamazepine has been researched along with Glomerulonephritis, Membranous in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.

Research Excerpts

ExcerptRelevanceReference
"A 22-year-old male with Fabry disease presented with proteinuria during ERT with agalsidase-β and carbamazepine."8.12Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report. ( Aoyagi, J; Ito, T; Kanai, T; Yamagata, T, 2022)
"A 22-year-old male with Fabry disease presented with proteinuria during ERT with agalsidase-β and carbamazepine."4.12Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report. ( Aoyagi, J; Ito, T; Kanai, T; Yamagata, T, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kanai, T1
Ito, T1
Aoyagi, J1
Yamagata, T1

Other Studies

1 other study available for carbamazepine and Glomerulonephritis, Membranous

ArticleYear
Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report.
    Medicine, 2022, Feb-18, Volume: 101, Issue:7

    Topics: Adult; Carbamazepine; Enzyme Replacement Therapy; Fabry Disease; Glomerulonephritis, Membranous; Hum

2022